China
· Delayed Price · Currency is CNY Inner Mongolia Furui Medical Science Statistics
Total Valuation
Inner Mongolia Furui Medical Science has a market cap or net worth of CNY 9.96 billion. The enterprise value is 9.80 billion.
| Market Cap | 9.96B |
| Enterprise Value | 9.80B |
Important Dates
The last earnings date was Friday, October 25, 2024.
| Earnings Date | Oct 25, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Inner Mongolia Furui Medical Science has 266.03 million shares outstanding. The number of shares has increased by 0.82% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 266.03M |
| Shares Change (YoY) | +0.82% |
| Shares Change (QoQ) | +3.42% |
| Owned by Insiders (%) | 17.34% |
| Owned by Institutions (%) | 26.35% |
| Float | 204.02M |
Valuation Ratios
The trailing PE ratio is 76.14 and the forward PE ratio is 51.04.
| PE Ratio | 76.14 |
| Forward PE | 51.04 |
| PS Ratio | 7.48 |
| PB Ratio | 6.35 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 321.68 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.33, with an EV/FCF ratio of 316.62.
| EV / Earnings | 75.16 |
| EV / Sales | 7.39 |
| EV / EBITDA | 26.33 |
| EV / EBIT | 34.45 |
| EV / FCF | 316.62 |
Financial Position
The company has a current ratio of 3.88, with a Debt / Equity ratio of 0.03.
| Current Ratio | 3.88 |
| Quick Ratio | 3.25 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.18 |
| Debt / FCF | 2.15 |
| Interest Coverage | 267.73 |
Financial Efficiency
Return on equity (ROE) is 11.30% and return on invested capital (ROIC) is 9.10%.
| Return on Equity (ROE) | 11.30% |
| Return on Assets (ROA) | 6.58% |
| Return on Capital (ROIC) | 9.10% |
| Revenue Per Employee | 1.89M |
| Profits Per Employee | 185,493 |
| Employee Count | 703 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 2.99 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +15.39% in the last 52 weeks. The beta is -0.33, so Inner Mongolia Furui Medical Science's price volatility has been lower than the market average.
| Beta (5Y) | -0.33 |
| 52-Week Price Change | +15.39% |
| 50-Day Moving Average | 42.43 |
| 200-Day Moving Average | 46.23 |
| Relative Strength Index (RSI) | 39.13 |
| Average Volume (20 Days) | 18,437,469 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Inner Mongolia Furui Medical Science had revenue of CNY 1.33 billion and earned 130.40 million in profits. Earnings per share was 0.49.
| Revenue | 1.33B |
| Gross Profit | 991.56M |
| Operating Income | 284.51M |
| Pretax Income | 273.48M |
| Net Income | 130.40M |
| EBITDA | 358.58M |
| EBIT | 284.51M |
| Earnings Per Share (EPS) | 0.49 |
Balance Sheet
The company has 547.35 million in cash and 66.48 million in debt, giving a net cash position of 480.86 million or 1.81 per share.
| Cash & Cash Equivalents | 547.35M |
| Total Debt | 66.48M |
| Net Cash | 480.86M |
| Net Cash Per Share | 1.81 |
| Equity (Book Value) | 1.93B |
| Book Value Per Share | 5.89 |
| Working Capital | 978.98M |
Cash Flow
In the last 12 months, operating cash flow was 224.90 million and capital expenditures -193.95 million, giving a free cash flow of 30.96 million.
| Operating Cash Flow | 224.90M |
| Capital Expenditures | -193.95M |
| Free Cash Flow | 30.96M |
| FCF Per Share | 0.12 |
Margins
Gross margin is 74.75%, with operating and profit margins of 21.45% and 9.83%.
| Gross Margin | 74.75% |
| Operating Margin | 21.45% |
| Pretax Margin | 20.62% |
| Profit Margin | 9.83% |
| EBITDA Margin | 27.03% |
| EBIT Margin | 21.45% |
| FCF Margin | 2.33% |
Dividends & Yields
Inner Mongolia Furui Medical Science does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -0.82% |
| Shareholder Yield | -0.82% |
| Earnings Yield | 1.31% |
| FCF Yield | 0.31% |
Stock Splits
The last stock split was on July 6, 2015. It was a forward split with a ratio of 2.
| Last Split Date | Jul 6, 2015 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Inner Mongolia Furui Medical Science has an Altman Z-Score of 9.5.
| Altman Z-Score | 9.5 |
| Piotroski F-Score | n/a |